57.48 USD
▲-0.59+0.54%
盘后 59.16 +1.26%
2026-07-31
市值
$33.10B
市盈率
30.19
EPS
1.90
股息率
1.61%
52 周区间
34.08 – 60.44
成交量
3.68M
Beta
0.42
目标价
59.89
52W 低 34.0852W 高 60.44
价格走势
公司简介
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune ...